Ambulatory blood pressure monitoring (ABPM) is cost-saving across nearly all age groups, regardless of whether patients are found to have hypertension on the initial screening, according to a study published in Hypertension.

Mylan Pharmaceuticals expanded its voluntary drug recall to include all unexpired valsartan-containing products in the U.S., the FDA announced Dec. 4. The action joins a host of other recalls over the last few months related to carcinogenic impurities being found in angiotensin II receptor blockers (ARBs), a class of medications used to treat hypertension and heart failure.

Contrary to U.S. guidelines, early action against high BP in patients exhibiting signs of hypertension doesn’t reduce their risk of heart disease later in life, according to a study published in the European Heart Journal Nov. 21.

Smoke-free policies in public places like bars and restaurants were linked to lower systolic blood pressures (SBPs) among participants from the longitudinal CARDIA study, according to new research published in the Journal of the American Heart Association.

Just 45 minutes of chatting with a second-year medical student could improve disease management among patients with chronic conditions like hypertension, diabetes and chronic obstructive pulmonary disease (COPD), according to research published in the November issue of the Journal of the American Osteopathic Association.

A study of two neighboring communities living in the remote Venezuelan rainforest is poking holes in the idea that blood pressure inevitably increases with age.

A third blood pressure drug has been recalled over a carcinogenic impurity, the FDA announced Nov. 8.

Exposure to blue light could decrease an individual’s systolic blood pressure by as much as 8 mm Hg in just half an hour, researchers report in a study co-led by the University of Surrey, Heinrich Heine University Düsseldorf and Philips.

It’s not just what people eat—but when—that may influence their risk of developing prediabetes and high blood pressure, according to preliminary research scheduled to be presented Nov. 10 at the American Heart Association’s Scientific Sessions in Chicago.

Climbing rates of violent crime could trigger blood pressure (BP) spikes within nearby communities—particularly among individuals living in what are considered “safe” neighborhoods—according to a study of 50,000 adults living in Chicago.

Low-risk patients with mild hypertension derived no protective benefit from blood pressure drugs over 5.8 years of follow-up but had an increased risk of adverse effects potentially related to the medication, researchers reported in a new study.

ScieGen Pharmaceuticals has issued a recall of the blood pressure drug irbesartan after lab testing revealed a carcinogenic impurity, the FDA announced in a MedWatch Safety Alert.